Scynexis (SCYX) Short-term Investments (2016 - 2026)
Scynexis (SCYX) posted Short-term Investments of $80000.0 for Q1 2026, little changed on a QoQ basis from $80000.0 in Q4 2025, and down 81.61% year-over-year from $435000.0 in Q1 2025.
Scynexis (SCYX) Short-term Investments (2016 - 2026) Analysis & Trends
Scynexis' Short-term Investments history runs 11 years deep, the most recent figure standing at $80000.0 for Q1 2026.
- Quarterly Short-term Investments fell 81.61% year-over-year to $80000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80000.0 (down 81.61% YoY) and the FY2025 annual result came in at $80000.0, down 81.61% from the prior year.
- Short-term Investments was $80000.0 for Q1 2026 at Scynexis, roughly flat from $80000.0 in the prior quarter.
- Across five years, Short-term Investments topped out at $47.0 million in Q2 2024 and bottomed at $55000.0 in Q3 2022.
- A 5-year average of $9.3 million and a median of $380000.0 in 2023 frame the typical range for Short-term Investments.
- Peak annual rise in Short-term Investments reached 590.91% in 2023, while the deepest fall reached 98.63% in 2023.
- Scynexis' Short-term Investments stood at $27.7 million in 2022, then tumbled by 98.63% to $380000.0 in 2023, then increased by 14.47% to $435000.0 in 2024, then tumbled by 81.61% to $80000.0 in 2025, then changed by 0.0% to $80000.0 in 2026.
- Business Quant data shows SCYX's Short-term Investments at $80000.0 in Q1 2026, $80000.0 in Q4 2025, and $80000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 33.77 Mn |
| Mar 31, 2025 | 435,000.00 |
| Dec 31, 2024 | 435,000.00 |
| Sep 30, 2024 | 435,000.00 |
| Jun 30, 2024 | 47.04 Mn |
| Mar 31, 2024 | 380,000.00 |
| Dec 31, 2023 | 380,000.00 |
| Sep 30, 2023 | 380,000.00 |
| Jun 30, 2023 | 27.64 Mn |
| Mar 31, 2023 | 55,000.00 |
| Dec 31, 2022 | 27.69 Mn |
| Sep 30, 2022 | 55,000.00 |
| Jun 30, 2021 | 55,000.00 |
| Mar 31, 2021 | 55,000.00 |
| Jun 30, 2020 | 3.59 Mn |
| Mar 31, 2020 | 14.27 Mn |
| Dec 31, 2019 | 6.49 Mn |